EPISODE · Feb 3, 2025 · 31 MIN
Dr. David Golden Discusses the Latest Anaphylaxis Guidelines and More
from ImmunoCAST · host Thermo Fisher Scientific
Dr. David Golden is a member of the Joint Task Force on Practice Parameters and has directed research programs on insect allergy and anaphylaxis at Johns Hopkins for 30 years, publishing numerous research and review articles. In this episode we speak with Dr. Golden about the latest updates to the anaphylaxis practice parameters, emphasizing critical changes in recommendations around the role of epinephrine and more. Transitioning to stinging insect venom allergy, we discuss the effectiveness of venom immunotherapy, the role of testing with allergen components in tailoring treatment, and the impact of risk stratification on patient quality of life. Gain valuable insights into diagnostic strategies and management techniques that can enhance patient care and reduce fear associated with insect sting allergies. Episode resources and references available at https://www.thermofisher.com/phadia/us/en/resources/immunocast/doctor-david-golden-and-latest-anaphylaxis-guideline-updates.html?cid=0ct_3pc_05032024_9SGOV4
Embed this episode
Ready to play
Dr. David Golden Discusses the Latest Anaphylaxis Guidelines and More
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.